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Abstract 
Estrogen has been shown to augment satellite cell activation, proliferation and 
total number and that this may occur through an estrogen receptor (ER) mediated 
mechanism. The purpose of this study was to investigate the role of ERs in the post-
exercise estrogen-induced augmentation of satellite cells in skeletal muscle of 
ovariectomized rats. Furthermore, the specific role of the ERa was examined through 
the use of an ERa agonist, propyl pyrazole triol (PPT). Ovariectomized rats were used 
(n=64) and separated into 4 groups: sham, estrogen supplemented, agonist 
supplemented and a combined estrogen and agonist supplemented group. These 
groups were further subdivided into control (unexercised) and exercise groups. 
Animals in the exercise group participated in an intermittent running protocol that 
involved animals running downhill on a motorized treadmill for 90 minutes. Surgical 
removal of white vastus and soleus muscles occurred 72 hours post-exercise. Muscle 
samples were immunostained for the satellite cell markers Pax7 and MyoD. 
Significant increases in total (Pax7-positive) and activated (MyoD-positive) satellite 
cells were found in all groups post-exercise. A further significant augmentation of 
total and activated satellite cells occurred in estrogen supplemented, agonist 
supplemented and the combined estrogen and agonist supplemented groups post-
exercise in white vastus and soleus muscles relative to unsupplemented animals. These 
results demonstrate that both estrogen and the ERa agonist, PPT, can significantly 
augment satellite cell number and activation following exercise-induced muscle 
damage. This suggests that estrogen acts through an ER-mediated mechanism to 
stimulate satellite cell activation and proliferation following exercise, with ERa 
playing a primary role. 
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Chapter One 
Introduction 
A fundamental role of skeletal muscle is the production of gross and fine 
movements. Skeletal muscle is made up of fibres that contain specialized contractile 
proteins that allow for muscle force generation and contraction to occur. Damage 
sustained by muscle fibres can cause pain, swelling and ultimately impair skeletal muscle 
function (Maclntyre et al., 1995; Proske & Allen, 2005). Muscle repair mechanisms 
therefore play a vital role in the proper and optimal functioning of skeletal muscle. Key 
components of the indices of muscle damage, inflammation and repair are further 
discussed below. 
1.1 Skeletal Muscle Damage 
Skeletal muscle damage involves the disruption of muscle fibres and can result 
from a variety of factors including exercise, muscular trauma, overuse injuries and 
ischemia reperfusion (I/R) injuries (Armstrong et al., 1983; Gute et al., 1998; Silverman, 
2007). In order to elicit muscle damage, many studies employ exercise regimes that 
involve eccentric contractions. Eccentric contractions occur when the muscle produces 
force as it lengthens. Numerous studies have demonstrated that eccentric contractions 
produce significantly more damage to muscle tissue than concentric contractions 
(Clarkson & Sayers, 1999; Gibala et al., 1995). There are various mechanical factors that 
play a role in this fact. Eccentric muscle contractions require the recruitment of fewer 
motor units and muscle fibres than concentric contractions and therefore increase the 
strain per fibre, causing more damage. Additionally, a smaller cross-sectional area of the 
1 
muscle is loaded, increasing the subsequent amount of damage (Enoka, 1996). Moreover, 
recruitment of structures not typically involved in excitation-contraction coupling, such 
as tendons, can occur during eccentric contractions (Brown et al., 1997). Morgan (1990) 
proposed a theory to explain this phenomenon. He stated that during eccentric 
contractions some sarcomeres become overextended and "pop," resulting in a decreased 
or total lack of overlap of the actin and myosin myofilaments in that particular sarcomere. 
In order to maintain the load, the activation of tendons then becomes necessary, which 
can increase the degree damage within the muscle. 
Histological evidence of muscle damage to the sarcolemma, sarcoplasmic 
reticulum, myofibrils and the cytoskeleton following eccentric exercise have been 
demonstrated in numerous studies (Armstrong et al., 1983; Friden et al., 1984; Trappe et 
al., 2002; Yu et al., 2003). The cytoskeleton of skeletal muscle fibres is composed of a 
variety of proteins including titin, desmin, a-actinin, nebulin and dystrophin. These 
proteins act to stabilize actin, myosin and the sarcomere as a whole (Morgan & Allan, 
1999). Exercise-induced damage, particularly from eccentric contractions, can damage 
these cytoskeletal proteins causing Z disc streaming to occur. Z disc streaming is a 
common feature of exercise-induced muscle damage where the Z discs of some 
sarcomeres are disrupted or torn (Figure 1). This type of damage has been shown in 
human muscle biopsies following eccentric contractions (Newham et al., 1983; 
Nurenberg et al., 1992; Gibala et al., 1995; Gibala et al., 2000). 
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Figure 1; An electron micrograph from a human leg muscle biopsy sample following an 
eccentric exercise protocol. The arrows indicate Z-disc streaming in two sarcomeres 
(Nurenberg et al., 1992). 
Secondary damage (damage occurring following the initial injury) to the muscle 
can occur post-exercise via the stimulation of non-lysosomal proteases including calpain 
(Brooks et al., 1983; Van der Westuyzen et al., 1981; Zenman et al., 1985). Calpain has 
three isoforms: calpain-1, calpain-2 and calpain-3. While calpain-3 is involved in skeletal 
muscle maintenance, acting to aid in the removal of cellular debris within the sarcomere 
(Beckmann & Spencer, 2008), calpain-1 and calpain-2 act in a proteolytic fashion 
contributing to the damage of the sarcoplasmic reticulum, connective tissue, contractile 
tissue and mitochondrial swelling in skeletal muscle following intense exercise or 
eccentric contractions (Brown et al., 1997; Duncan, 1987; Verburg et al., 2009). 
Furthermore, since 2-5% of the total amount of calpain in the muscle fibre is located at 
the I and Z bands, it is thought that calpain-1 and calpain-2 may play a role in the 
degradation of cytoskeletal proteins in the Z disc (Belcastro et al., 1988; Verburg et al., 
2009). Belcastro et al. (1988), for example, found a significant decrease in two proteins, 
58 Kda and 95 Kda, following exercise-induced muscle damage. These two proteins 
could correspond to desmin and a-actinin, both of which make up a large portion of the Z 
disc. Furthermore, studies conducted in vitro have demonstrated the ability of calpain-1 
and calpain-2 to cleave various proteins including desmin, which can cause the release of 
a-actinin, contributing to Z disc streaming (Goll et al., 1991; Saido et al., 1994; Verburg 
et al., 2009). These results show a plausible link between exercise-induced muscle 
damage, the activation of calpain and the resulting breakdown of a-actinin and desmin; 
contributing to Z disc streaming and further damage to the muscle fibre. 
Numerous studies support post-exercise induced muscle damage by calpain 
following eccentric exercise. Since calpain is activated by calcium, in skeletal muscle, 
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intracellular levels of calcium must increase following exercise in order for this damage 
to occur. Duncan (1987) demonstrated this in a study that utilized skinned amphibian 
pectoris cutaneous muscle where an increased intracellular calcium concentration caused 
cellular damage including Z disc streaming, loss of myofibril organization and 
mitochondrial swelling. Similarly, treatment of skeletal muscle with the calcium ionphore 
(A23187) increased the intracellular calcium concentration within the muscle fibre and 
caused ultrastructural damage to occur (Publicover et al., 1978). Warren et al. (1995) has 
linked eccentric exercise to an increase in free cytosolic calcium levels in the muscle cell 
and an associated damage to the sarcolemma. Overall, the concentration of calcium 
within the muscle not only plays a role in excitation-contraction coupling and cross-
bridge formation but it also can activate calpain-1 and calpain-2, leading to proteolysis of 
muscle tissue. Eccentric exercise was used in this study as a means to elicit exercise-
induced muscle damage due to the strong relationship between eccentric contractions, 
calpain-1 and calpain-2 activation and the subsequent skeletal muscle damage. 
Another source of secondary injury to muscle, which is also involved in initiating 
the muscle repair process, is the inflammatory response. 
1.2 The Inflammatory Response 
Following eccentric exercise and its associated muscle fibre damage, an 
inflammatory response is initiated involving the migration of leukocytes and other 
chemotactic agents to the site of injury (Clarkson & Sayers, 1999). Early stages of 
damage are characterized by an infiltration of neutrophils, followed by an increase in 
macrophages ED1+ and ED2+ to the site of injury (Tidball, 1995). 
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Neutrophils 
Neutrophils are thought to be the first cells to migrate to the site of damage in 
skeletal muscle (Tidball, 1995). Fielding et al. (1993) demonstrated an accumulation of 
neutrophils in skeletal muscle 45 minutes following eccentric exercise in humans and this 
neutrophil accumulation remained for 5 days. The infiltration of neutrophils to the site of 
injury typically peaks at 12 to 24 hours post-injury, however. While the exact function of 
neutrophils is not known, it is postulated that they are involved in the removal of cellular 
debris and in stimulating the migration of macrophages to the site of injury (Maclntryre 
et al., 1995; Teixeira et al., 2003; Tidball, 1995). Neutrophils may also play a role in 
secondary muscle damage as their infiltration to the site of damage can lead to the 
production of reactive oxygen species including superoxide. Reactive oxygen species 
cause cellular damage including peroxidation of membrane lipid bilayers and the 
disruption of functional proteins, all of which can contribute to secondary damage post-
exercise. This is a controversial topic, however, with studies showing support for 
(Nguyen and Tidball, 2003; Pizza et al., 2005) and against (Armstrong et al., 1983; 
Lapointe et al., 2002) secondary muscle damage caused by neutrophil infiltration. 
Macrophages 
Infiltration of macrophages to the site of damage in skeletal muscle is necessary 
for muscle regeneration to occur. This accumulation of macrophages peaks at 48 hours 
following injury (Hawke & Garry, 2001). Removal of cellular debris and necrotic tissue 
via phagocytosis is the primary role of macrophages in the inflammatory response; more 
specifically, it is postulated that this is completed by ED1+ macrophages (Lapointe et al., 
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2002; Lescaudron et al., 1999). Studies have shown that ED2 macrophages, on the other 
hand, do not participate in the removal of cellular debris but may play a role in the 
proliferation of satellite cells post-injury (Cantini et al., 1994; McLenna, 1993; St. Pierre 
& Tidball, 1994). In support of this, St. Pierre et al. (1994) demonstrated an accumulation 
of EDI+ macrophages in damaged myofibres 2 days following muscle reloading in mice, 
whereas ED2+ macrophages reached a peak accumulation 4 days following muscle 
reloading and were not directly involved in phagocytosis. Lescaudron et al. (1999) also 
demonstrated that muscle regeneration does not precede the infiltration of macrophages 
to the site of injury in vivo, providing evidence that macrophages may play a role in 
muscle regeneration. While this study does not examine the inflammatory response, the 
infiltration of neutrophils and macrophages to the site of damage in skeletal muscle plays 
an essential role in satellite cell signalling and activation, which this study did measure. 
1.3 Muscle Repair: Satellite Cells 
The term satellite cell was first coined by Alexander Mauro (1961) after their 
discovery in 1961. Satellite cells are mononucleated and fusiform in shape and reside 
between the basil lamina and the sarcolemma of muscles, running parallel to the 
myofibres. Since terminal differentiation of skeletal myocytes occurs in vertebrates, 
satellite cells are present to function as stem cells within skeletal muscle, aiding in 
postnatal muscle repair and regeneration (Mauro, 1961; Muir et al., 1965). 
Until activated by various stimuli, satellite cells remain in a quiescent, 
undifferentiated state with a high nuclear-to-cytoplasmic ratio and few organelles (Muir 
et al., 1965; Schultz, 1976). In addition, the nucleus within a satellite cell is small and 
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contains a greater amount of condensed chromatin compared to myonuclei (Schultz, 
1976). Stimuli that can activate satellite cells include myotrauma, ischemia, exercise and 
disease (Schultz & McCormick, 1994). Upon activation, satellite cells undergo a 
reduction in chromatin and an increase in organelle content and cytoplasmic-to-nuclear 
ratio. An increase in mitotic activity via entry into the cell cycle occurs as well, leading to 
the proliferation of satellite cells (Schultz & McCormick, 1994). Proliferation of satellite 
cells peaks 2 to 3 days following the myotrauma but can continue for up to 5 days post-
trauma. At this point in time, satellite cells withdraw from the cell cycle and differentiate. 
When satellite cells differentiate, fusion into existing myofibres can occur, contributing 
to hypertrophy. In addition, satellite cells can align and fuse together forming a new 
myotube which is known as hyperplasia (Figure 2). The fate of a differentiating satellite 
cell depends on the severity of the damage and muscle regeneration is typically complete 
10 days following the myotrauma (Garry et al., 1997; Hawke & Garry, 2001; Schultz & 
McCormick, 1994). 
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Figure 2: The satellite cell cycle (Hawke & Garry, 2001). 
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Satellite Cell Markers 
There are various markers for satellite cell identification that are expressed or 
incorporated by satellite cells at different phases of activation. Some commonly used 
immunohistochemical markers include 5-bromo-2'-deoxyuridine (BrdU), MyoD and 
Pax7. BrdU is a thymine analog that identifies proliferating satellite cells (Hawke & 
Garry, 2001). BrdU becomes incorporated into the DNA of proliferating satellite cells 
acting as a nonradioactive marker that can identify replicating cells in vivo (Hurme & 
Kalimo, 1991). 
Pax7 and MyoD are transcription factors that are common markers for satellite 
cell identification. Pax7 marks quiescent, activated and proliferating satellite cells 
(Hawke & Garry, 2001). MyoD, on the other hand, is not expressed in quiescent satellite 
cells but becomes up-regulated within 12 hours following muscle injury (Seale & 
Rudnicki, 2000). Activated satellite cells express MyoD and studies have shown that 
proliferating satellite cells express MyoD as well as other markers including Myf5 and 
desmin (Cornelison & Wold, 1997). Furthermore, studies utilizing MyoD(-/-) mice have 
demonstrated a continued proliferation of satellite cells while in the presence of 
differentiation-favoured conditions. As a result, it is postulated that MyoD may also play 
a role in satellite cell differentiation (Sabourin et al., 1999). 
This study measured satellite cells 72 hours post-exercise utilizing Pax7 and 
MyoD as positive satellite cell markers. This time period was chosen as numerous studies 
have demonstrated the presence of peak levels of activated and proliferating satellite cells 
72 hours post-exercise (Armstrong et al , 1983; Hawke & Garry, 2001; Hurme et al., 
1991). Furthermore, Enns & Tiidus (2008) demonstrated that satellite cells labelled by 
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Pax7 peak at 3 days post-exercise and MyoD-labelled satellite cells peak at 2-3 days post-
exercise when using the exercise protocol employed by this study. 
Satellite Cell Regulation 
Satellite cell activity may be regulated by numerous factors. It has been postulated 
that the extracellular matrix of skeletal muscle fibres store growth factors that are 
released through tears in the sarcolemma following eccentric exercise (Tatsumi et al., 
1998). The release of these growth factors into the muscle fibre may play a role in the 
regulation of satellite cell activation, proliferation and differentiation. Hepatocyte growth 
factor (HGF), insulin-like growth factor (IGF-I), fibroblast growth factor (FGF), 
leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) are some such factors that may 
play a role in satellite cell regulation. These factors are further discussed below. 
Hepatocyte Growth Factor (HGF) 
HGF is a cytokine that acts on the c-met receptor located on satellite cells 
(Bischoff, 1997; Tatsumi et al., 1998). It is secreted by myoblasts (Anastasi et al., 1997) 
and by damaged tissue within the muscle (Cornelison & Wold, 1997; Tatsumi et al., 
1998). Proposed roles for the action of HGF include the activation and proliferation of 
satellite cells (Allen et al., 1995; Tatsumi et al., 1998). Additionally, HGF acts as a 
chemoattractant where its release from damaged muscle tissue may allow satellite cells to 
migrate to the site of injury by chemotaxis (Bischoff, 1997). Gal-levi et al. (1998) also 
demonstrated that treatment of quiescent satellite cells with HGF caused the activation of 
satellite cells by triggering entry into the cell cycle, shown by an increase in DNA 
synthesis. Gal-levi et al. (1998) further demonstrated that HGF not only plays a role in 
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the activation and proliferation of satellite cells but it also inhibits differentiation by 
inhibiting transcriptional factors necessary for differentiation, including MyoD and 
myogenin. 
Insulin-like Growth Factor-I (IGF-I) 
IGF-I is secreted by skeletal muscle and plays a role in the promotion of satellite 
cell proliferation and differentiation (Chakravarthy et al., 2000; Hawke & Garry, 2001; 
Johnson et al., 1990; Mills et al., 2007). Chakravarthy et al. (2000), for example, 
demonstrated the proliferative capability of IGF-I where its injection into atrophied 
skeletal muscle of rats was followed by a significant increase in the proliferation of 
satellite cells compared to controls, leading to a significant increase in muscle mass. 
Furthermore, numerous studies have also shown that IGF-I plays a role in increasing 
skeletal muscle mass, strength and hypertrophy (Barton et al., 2007; Barton-Davis et al., 
1998; Musaro et al., 1999). Since up-regulation of IGF-I occurs following eccentric 
exercise in humans (Hameed et al., 2007) and rats (Adams et al., 1998), IGF-I may be a 
key factor in skeletal muscle regeneration through the regulation of satellite cell 
proliferation and differentiation. 
Fibroblast growth factor (FGF) 
FGF is a cytokine that, like IGF-I, plays a role in satellite cell proliferation. A 
study by Floss et al. (1997) examined the role of FGF-6, an isoform of FGF, which is 
solely found in skeletal muscle. Using FGF-6 deficient mice, FGF-6(-/-), it was shown 
that following a crush injury, these mice had an impaired ability for muscle regeneration 
compared to mice with the FGF-6 gene. The authors postulated that FGF-6 may play a 
significant role in satellite cell activation or proliferation (Floss et al., 1997). The role that 
12 
FGF plays in the regulation of satellite cells was further examined by Scanta et al. (1999) 
who demonstrated that increasing the FGF receptor availability lead to an increase in 
satellite cell proliferation and a decrease in differentiation. Furthermore, decreasing FGF 
receptor availability lead to a decrease in satellite cell proliferation and an increase in 
differentiation of myocytes. This data shows that FGF plays a role in satellite cell 
proliferation and differentiation and that this may be regulated in part by receptor number 
and/or availability. 
Leukemia inhibitory factor (LIF) & interleukin-6 (IL-6) 
LIF and IL-6 belong to the same family of cytokines and are produced by a 
variety of cells including macrophages and myoblasts (Hawke & Garry, 2001; Hibi et al., 
1996). LIF and IL-6 play a role in satellite cell regulation by stimulating cell proliferation 
(Austin & Burgess, 1991; Hawke & Garry, 2001). Kurek et al. (1997) utilized LIF(-/-) 
mice to demonstrate the regenerative role of LIF in vivo as the LIF knockout mice had a 
significantly decreased capacity for muscle regeneration following a muscle crushing 
injury. Cantini et al. (1995) examined IL-6 and demonstrated that it is released by 
activated satellite cells and macrophages, promoting satellite cell proliferation. IL-6 also 
acts directly on macrophages and neutrophils to induce cellular apoptosis and is therefore 
a regulator of both satellite cell proliferation and the inflammatory process. During 
satellite cell proliferation there are an increased number of satellite cells present and a 
consequent increase in the amount of IL-6 released. This is a regulatory mechanism that 
may act to ensure that the breakdown of macrophages and neutrophils occur at the site of 
injury while new myocytes and myotubes are being formed (Cantini et al., 1995). 
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Overall, there are many growth factors that play a role in satellite cell regulation. 
Satellite cells may also be regulated by a variety of other factors including nitric oxide, 
transforming growth factors, platelet-derived growth factor and hormones such as insulin 
and testosterone (Hawke & Garry, 2001). In order to further understand the skeletal 
muscle repair process, it is important to elucidate the mechanism of satellite cell activity 
and the circumstances in which the factors described above will act to regulate satellite 
cell activity. This study looked specifically at a potential mechanism of estrogen 
influence on post-exercise satellite cell activation and proliferation. 
1.4 The Role of Estrogen 
Estrogens are steroid sex hormones that include estradiol, estrone and estriol. 
Estradiol is produced by the ovaries and is the primary estrogen in the body (Wierman, 
2007). In the past it was typically assumed that sex hormones target sex organs alone, 
however, recent studies have indicated that sex hormones, such as estrogen, have a 
number of target organs including skeletal muscle (Enns et al., 2008; Wang et al., 1999). 
Estrogen has two distinct receptors, estrogen receptor alpha (ERa) and estrogen receptor 
beta (ER(3). Both receptors are expressed in skeletal muscle, though they are encoded by 
separate genes (Hall et al., 2001; Wiik et al., 2003). In addition, ERa and ER|3 have a 
similar binding affinity for endogenous and synthetic estrogens and can be activated 
when bound with a ligand (Hall et al., 2001; Kalbe et al., 2007). 
Estrogen plays a role in skeletal muscle through its influence on muscle damage, 
inflammation and repair. Following various exercise protocols, sex differences in the 
degree of sustained muscle damage have been found. Komulainen et al. (1999), for 
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example, demonstrated an increase in cytoskeletal damage in male rats following an 
eccentric exercise protocol, compared to female rats. Estrogen has also been shown to 
attenuate damage caused by I/R injury and exercise-induced damage. In studies utilizing 
a rat forebrain ischemia model, administration of 17P-estradiol was shown to reduced I/R 
injury (Santizo et al., 2000; Wang et al., 1999). 
The presence of estrogen has also been shown to influence inflammation by 
attenuating neutrophil and macrophage infiltration in skeletal muscle following injury. 
Stupka & Tiidus (2001) presented the first study examining the effects of estrogen on 
leukocyte infiltration following an I/R-induced injury. Estrogen was shown to exert a 
protective effect on skeletal muscle and attenuated the infiltration of neutrophils in 
female rats following I/R injury. The relationship between estrogen and neutrophil 
infiltration following exercise-induced damage was further examined by Tiidus et al. 
(2001) in ovariectomized (OVX) rats. Neutrophil infiltration in the estrogen-
supplemented rats was significantly reduced post-exercise compared to the exercised 
placebo group. In addition, myeloperoxidase activity, a marker for neutrophil infiltration, 
was significantly reduced in the exercised estrogen group 1 hour post-exercise. These 
studies demonstrate the attenuation of neutrophil accumulation in damaged skeletal 
muscle in female, OVX rats with estrogen replacement. The same attenuation of 
neutrophil infiltration was demonstrated in estrogen supplemented male rats, suggesting 
that the presence of physiological levels of estrogen alone is sufficient to cause this 
reduction in neutrophil infiltration (Tiidus & Bombardier, 1999). 
The relationship between estrogen and satellite cell activation in damaged skeletal 
muscle has also been examined. A study by Tiidus et al. (2005) demonstrated that 
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eccentrically exercised, estrogen-supplemented male rats had a significantly greater 
number of satellite cells present in the soleus and white vastus muscles at 72 hours post-
exercise, compared to exercised male rats without estrogen-supplementation. The satellite 
cells in this study were identified by the marker Pax7 and it was therefore not known 
what stage of activation the identified satellite cells were in. Further investigation was 
conducted by Enns & Tiidus (2008), where OVX female rats underwent an eccentric 
exercise running protocol to induce skeletal muscle damage. The number of satellite cells 
present 72 hours post-exercise was then examined with the markers Pax7, MyoD and 
BrdU. This immunohistochemical analysis showed a significantly greater increase in 
total, activated and proliferating satellite cells post-exercise in the estrogen-supplemented 
exercised animals, compared to the exercised group without estrogen-supplementation. 
The results of this study suggest that estrogen may play a role in the activation of satellite 
cells following exercise-induced damage (Enns & Tiidus, 2008). 
While the exact mechanism of estrogen on the skeletal muscle repair process is 
not fully understood, possible mechanisms have been proposed. It is thought that these 
mechanisms may involve an increased activation of signalling proteins that are necessary 
for protein synthesis. The Akt-mammalian target of rapamycin (Akt-mTOR) pathway, for 
example, regulates protein synthesis in the muscle and estrogen has been shown to 
stimulate this pathway in cardiac muscle (Sitnick et al., 2006). Stimulation of the Akt-
mTOR pathway by estrogen causes mTOR to phosphorylate and activate a signalling 
protein, p70s6k. This leads to the phosphorylation of S6, a ribosomal protein, causing 
increased translation of mRNA that encodes proteins necessary for protein synthesis in 
muscle. In support of this pathway as a mechanism for the influence of estrogen on 
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skeletal muscle growth, Sitnick et al. (2006), observed a decrease in the activation of Akt 
and p70sk6 in OVX rats during muscle reloading, inhibiting muscle growth. 
Another pathway that may affect the skeletal muscle repair process is the 
phosphatidylinositol 3-kinase-Akt (PI3 kinase-Akt) pathway. Results from Patten et al. 
(2004) demonstrated an increased activation of PI3 kinase-Akt signalling by estrogen in 
cardiac muscle via interaction with the ERa. Interaction between ERa and p85, a 
regulatory subunit of PI3-kinase-Akt, causes an increase in the activation of this pathway 
which stimulates protein synthesis and muscle growth (Patten et al., 2004; Pedram et al., 
2002; Sitnick et al., 2006). Since ERa's are present in skeletal muscle, activation of the 
PI3-kinase-Akt pathway, via estrogen-ERa binding and the subsequent interaction with 
p85, may be a possible mechanism to explain how estrogen augments satellite cell 
activation and proliferation following muscle damage. 
The participation of an estrogen receptor (ER) mediated pathway as a potential 
mechanism for satellite cell activation and proliferation in skeletal muscle is supported by 
Enns et al. (2008) where an ER antagonist, ICI 182,780, was used to completely block 
ERs. This blocking of ERs in estrogen-supplemented rats eliminated the estrogen-
induced augmentation of satellite cells in damaged muscle fibres post-exercise. In 
addition, Lemoine et al. (2002) demonstrated an association between exercise and ERas 
where a significant increase in ERa mRNA transcripts in skeletal muscle was found 
following endurance training. These studies support the involvement of ERs in skeletal 
muscle during exercise and muscle repair. 
In order to corroborate the results from Enns et al. (2008), which suggest that 
estrogen acts through an ER-mediated mechanism to augment satellite cell activation and 
17 
proliferation, this study utilized the ERa agonist propyl pyrazole triol (PPT). PPT is an 
ERa agonist that has a 50% greater binding affinity for the ERa compared to estrogen 
itself (Kraichely et al., 2000; Stauffer et al., 2000). Through ERa binding, PPT has been 
shown to mimic the actions of estrogen by preventing body weight increases and bone 
mineral density losses in ovariectomized rats (Harris et al., 2002). In addition, PPT 
stimulates uterine growth with the same effectiveness as estrogen (Harris et al., 2002; 
Katzenellenbogen et al., 1995). Use of the ERa agonist, PPT, coupled with the results 
from Enns et al. (2008) will give further confirmation for the role that ERs play in the 
skeletal muscle repair process while also allowing the specific role that ERa plays in 
satellite cell activation and proliferation to be determined. 
1.5 Research Applications 
This research is potentially relevant to post-menopausal women. Since post-
menopausal women have reduced levels of estrogen, these women may experience an 
increased susceptibility to muscle damage and delays in muscle regeneration and 
recovery. In fact, research has shown that post-menopausal women suffer higher rates of 
sarcopenia and tend to develop it at an earlier age compared to men (Sipila et al., 2001). 
Sarcopenia is a loss of muscle mass that typically affects those aged 65 and older and can 
severely affect one's muscle strength and functional ability (Thompson, 2007). 
Impaired satellite cell functioning has been implicated as a possible contributor to 
sarcopenia (Zammit et al., 2006). Given the role that estrogen plays in satellite cell 
augmentation it is possible that this impairment in satellite cells, and consequent decrease 
in muscle mass, may arise due to the reduction of estrogen levels in post-menopausal 
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women. Studies have shown that while physical activity is commonly used to counteract 
sarcopenia, estrogen supplementation in addition to increased physical activity, decreases 
the development of sarcopenia to a greater extent (Dionne et al., 2000). Moreover, it has 
been demonstrated that estrogen alone can improve muscle recovery and repair from 
disuse atrophy in animal models (McClung et al., 2006). By examining the relationship 
between estrogen and the skeletal muscle repair process, an increased body of knowledge 
regarding possible preventative or treatment measures for skeletal muscle loss caused by 
a reduction of estrogen may become available. This may ultimately lead to increases in 
mobility, muscular strength and overall quality of life for post-menopausal women. 
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Chapter Two 
The Influence of Propyl Pyrazole Triol on the Alpha Estrogen Receptor-Mediated 
Activation of Satellite Cells in Rat Skeletal Muscle 
Statement of Problem 
The purpose of this study was to investigate the role of the alpha estrogen receptor 
(ERa) on the activation and proliferation of satellite cells in skeletal muscle following 
eccentric exercise through the administration of an ERa agonist (PPT) to ovariectomized 
female rats supplemented with or without estrogen. 
Hypotheses 
1. Based on previous studies it was hypothesized that supplementation with estrogen 
would augment satellite cell activation and proliferation post-exercise. 
2. Administration of the ERa agonist, PPT, would mirror the effects of estrogen by 
augmenting satellite cell activation and proliferation post-exercise. 
3. A combined administration of estrogen and the agonist would also increase 
satellite cell activation and proliferation post-exercise. 
4. No significant differences in satellite cell activation and proliferation would exist 
between the estrogen supplemented, agonist supplemented and the combined 
estrogen and agonist supplemented animals post-exercise. 
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Introduction 
Repeated, high-intensity eccentric muscle contractions have been shown to elicit 
exercise-induced muscle damage (Proske & Allen, 2005). This sets in motion a series of 
well documented events: an inflammatory response in skeletal muscle that is 
characterized by the infiltration of neutrophils and macrophages to the site of injury 
(Tidball et al., 1995); and the activation and proliferation of satellite cells. Satellite cells 
are located between the basil lamina and the sarcolemma of skeletal muscle and are 
involved in the muscle repair process (Mauro, 1961; Muir et al., 1965). Satellite cells 
remain in a mitotically quiescent state until activated by certain stimuli, including 
myotrauma caused by eccentric exercise. Upon activation, satellite cells proliferate and 
migrate to the site of injury and differentiate to repair existing myofibres and/or form new 
myofibres (Hawke & Garry, 2001; Schultz & McCormick, 1994). 
Many studies have demonstrated sex differences on indices of muscle damage, 
inflammation and repair that are largely due to the female sex-hormone estrogen. 
Estrogen has been shown to decrease cytoskeletal damage caused by I/R injury and 
exercise-induced damage in rats (Komulainen et al, 1999; Santizo et al., 2000; Wang et 
al., 1999). The presence of estrogen has also been shown to attenuate neutrophil and 
macrophage infiltration in rat skeletal muscle following injury (Stupka & Tiidus, 2001; 
Tiidus & Bombardier, 1999; Tiidus et al., 2001). 
Estrogens' influence on satellite cells was first examined by Tiidus et al. (2005) 
where estrogen supplemented male rats showed a significant increase in the total number 
of satellite cells present post-exercise compared to a sham group with no estrogen. Enns 
& Tiidus (2008) conducted a follow-up study to determine which satellite cell stage is 
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influenced by estrogen using the satellite cell markers Pax7 (total), MyoD (activated) and 
BrdU (proliferating). A significant increase in the presence of all markers was observed, 
demonstrating that estrogen plays a role in the activation and proliferation of satellite 
cells, as well as increasing the total number present in myofibers post-exercise. 
While the exact mechanism that estrogen exerts its effect on the skeletal muscle 
repair process is not fully understood, possible mechanisms have been proposed. It is 
thought that these mechanisms involve an increased activation of signalling proteins that 
are necessary for protein synthesis. Estrogen, for example, has been shown to influence 
two such pathways: the phosphatidylinositol 3-kinase-Akt (PI3 kinase-Akt) pathway and 
the Akt-mammalian target of rapamycin (Akt-mTOR) pathway (Patten et al., 2004; 
Pedram et al., 2002; Sitnick et al., 2006). Results from Patten et al. (2004) demonstrated 
an increased activation of PI3 kinase-Akt signalling by estrogen in cardiac muscle via 
interaction with the ERa. Since ERa's are present in skeletal muscle (Hall et al., 2001; 
Kalbe et al., 2006), activation of the PI3-kinase-Akt pathway, via estrogen-ERa binding, 
may be a possible mechanism to explain how estrogen augments satellite cell activation 
and proliferation following muscle damage. 
In an attempt to elucidate the mechanism through which estrogen exerts its effect, 
Enns et al. (2008) utilized an estrogen antagonist, ICI 182,780, to study the estrogen 
receptor-mediated pathway in satellite cell activation and proliferation in skeletal muscle. 
This estrogen antagonist competitively binds to ERs with an extremely high affinity, 
preventing estrogen binding. OVX female rats were used with results showing a 
significant increase in total, activated and proliferating satellite cells post-exercise in rats 
supplemented with estrogen compared to those without estrogen. Use of the estrogen 
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antagonist, however, eliminated the observed estrogen-induced augmentation of total, 
activated and proliferating satellite cells post-exercise. This data, therefore, lends support 
to the theory that estrogen mediates satellite cell activation and proliferation in skeletal 
muscle through an estrogen receptor-mediated pathway. 
The purpose of this study was to further examine the estrogen receptor-mediated 
pathway in satellite cell augmentation resulting from exercise and estrogen 
supplementation. In order to address this issue the ERa agonist, PPT, was used to bind to 
and stimulate the skeletal muscle ERas, where the total number of satellite cells (Pax7-
positive) and activated satellite cells (MyoD-positive) were examined in unexercised and 
exercised, OVX rats. Use of PPT allowed for the specific role of the ERa in the skeletal 
muscle repair process to be established. Based on results from Enns et al. (2008), it was 
hypothesized that estrogen would act in a receptor-mediated fashion to augment the 
activated and total number of satellite cells present in rat skeletal muscle, as demonstrated 
by a significant but similar post-exercise increase in satellite cells in the estrogen 
supplemented, agonist supplemented and the combined estrogen and agonist 
supplemented animals. 
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Methods 
Animals 
This experimental protocol was approved by the Animal Care Committee at 
Wilfrid Laurier University and operated in accordance to the Canada Council on Animal 
Care. A total of 64 female Sprague-Dawley rats were used (Charles River Laboratories, 
LaSalle, QC) and surgical removal of their ovaries occurred at 9 weeks of age. The 
animals arrived to our laboratory approximately one week post-surgery and were housed 
two animals per cage, in a temperature-controlled environment with a 12:12 hour 
light/dark cycle. Animals were allowed access to food (Teklad 22/5 Rodent Diet, Harlan-
Teklad, Madison,WI) and water ad libitum. 
Experimental Design 
Upon arrival to our laboratory, animals were given one week to acclimatize to the 
environment. During the acclimatization period, the animals were randomly divided into 
4 groups: Sham (S), Estrogen supplemented (E), Agonist supplemented (A), and Estrogen 
and Agonist supplemented (EA). The animals were further subdivided into Unexercised 
Control (Con) and Exercise (Ex) groups within the 4 groups (Figure 3). Animal weights 
were recorded from the day of arrival until tissue collection. 
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n=16 
Ovariectomized female rats 
n=64 
Estrogen 
n=16 
Agonist 
n=16 
Estrogen + 
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Figure 3: Schematic outline of the experimental groups. Con = control (unexercised) 
condition; Ex = exercised condition. 
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Following the acclimatization period, the animals underwent pellet implantation 
or a sham surgery. These procedures all occurred under aseptic conditions where the rats 
were anaesthetized with gaseous isoflurane. A small incision, approximately 1 cm in 
length, was made in the skin folds of the neck and blunt dissection was used to separate 
the skin from the underlying connective tissue. Implantation of an estrogen pellet (0.25 
mg 17P-estradiol, 21-day time release pellet, Innovative Research of America, Sarasota, 
FL) underneath the skin occurred in groups E and EA. Groups S and A underwent a sham 
surgery which is identical to the procedure described for groups E and EA but did not 
include implantation of an estrogen pellet. Following the pellet implantation or sham 
procedure the incision was closed with Vetabond (3 M St Paul, MN). 
The ERa agonist PPT (Tocris, Ellisville, MO) was administered four days post-
surgery and three days prior to the exercise protocol. Each rat in the A and EA group 
received 0.5mg of PPT in a dimethyl sulfoxide (DMSO) vehicle per day, via a O.lmL 
subcutaneous injection for 6 days. The rats in group S and E received a O.lmL 
subcutaneous injection of DMSO daily for 6 days where the last injection occurred one 
day prior to tissue collection. This protocol was developed to ensure an appropriate, 
prolonged exposure of PPT to the skeletal muscle ERs. It was based on a study by Harris 
et al. (2002) where the same PPT protocol activated uterine ERs as demonstrated through 
a significant increase in uterine weight. 
The exercise protocol occurred seven days following the pellet implantation and 
sham surgery. This was to ensure optimal exposure of skeletal muscle ERs in groups E 
and EA to the estrogen hormone. All animals in the Ex groups participated in a non-
fatiguing exercise protocol where the animals ran downhill on a motorized rodent 
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treadmill with an electric shock grid (Columbus Instruments, Columbus, OH). The 
animals ran at approximately 17 m/min at a -13.5° grade. An intermittent protocol was 
used where the animals ran for 5 minutes, followed by 2 minutes of rest, for a total of 90 
minutes of running. This protocol elicits muscle damage to various muscles including the 
soleus and white vastus muscles (Komulainen et al., 1999). These muscles were selected 
due to their differing fibre types; the soleus is highly composed of type I fibres, while 
white vastus is predominantly composed of type lib fibres. One and two days prior to the 
exercise protocol the Ex rats underwent a familiarization period on the treadmill for 5 
minutes. This increased the comfort level of the rats on the treadmill and allowed the 90 
minute running session to be completed with greater ease and accuracy on the run day. 
Tissue Collection 
Previous research has established that positively labelled Pax7 and MyoD satellite 
cells peak 3 days following exercise (Enns & Tiidus, 2008). The Ex animals were, 
therefore, sacrificed 72 hours following completion of the running protocol; Con animals 
were sacrificed at the same time as the Ex animals. Animals were anesthetised with 
sodium pentobarbital (55 mg/kg i.p.). A toe web pinch was conducted to ensure loss of 
the withdrawal reflex prior to commencement of tissue collection. Blood samples were 
obtained from the femoral artery and were allowed to clot at room temperature. The 
samples were then centrifuged at 3000g for 10 min.; the serum was then removed and 
stored at -80°C until further analysis. 
The soleus and the white vastus muscles were then surgically removed. During 
removal, the muscle samples were rinsed in physiological saline to remove excess blood, 
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blotted dry and visible connective tissue was removed. Tissue samples for 
immunohistochemical analysis were mounted, coated in optimal cutting temperature 
(OCT) medium and frozen in isopentane that was chilled to the temperature of liquid 
nitrogen. All tissue samples were then immediately placed into liquid nitrogen until 
transferred to a -80°C environment. Samples remained at this temperature until analysis. 
See Figure 4 for a schematic outline of the experimental protocol. 
Serum Analysis 
Estrogen levels were analyzed via blood serum analysis using the Coat-a-Count 
radioimmunoassay kit (Inter Medico, Markham, ON). 
p-glucuronidase activity 
Using the Barrett method, the activity of p-glucuronidase was assessed (Barrett, 
1972). P-glucuronidase is a lysosomal hydrolase that is a marker of muscle damage, 
where increased activity indicates increased muscle damage (Salminen & Kihlstrom, 
1985). Performed in triplicate, muscle samples were assayed at 420 nm and activities are 
expressed as the amount of substrate (5 mM /?-nitrophenyl-|3-D-glucuronide, Sigma-
Aldrich) hydrolyzed per protein amount and incubation time. Protein concentration was 
measured using Lowry's method (Lowry et al., 1951). 
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Figure 4: Schematic outline of the experimental protocol timeline. 
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Immunohistochemical Analysis 
Using a cryostat (Leica CM3050S, Germany), muscle samples were transversely 
cut into 10 urn sections and placed onto Vactabond coated glass slides (Vector 
Laboratories, Burlington, ON). All slides were stored at -20°C until analysis. 
Immunohistochemical staining for markers of satellite cells, Pax7 ((Developmental 
Studies Hybridoma Bank, University of Iowa, Iowa City, IA) and MyoD (Dako Canada, 
Mississauga, ON) were completed. 
Quantification of satellite cells from the immunostains were conducted by placing 
the slides under a light microscope (Leica DMLS) that projects onto a computer screen at 
a magnification of 400x (lOx ocular and 40x objective lens). For each muscle sample, 2 
sections of 200 myofibers were counted for positive satellite cells, for a total of 400 
counted myofibers, as previously described (Enns et al., 2008; Enns & Tiidus, 2008). 
These measurements are considered to give an accurate representation of the relative 
number of satellite cells present since myofibers staining positively for more than one 
satellite cell was rarely observed (unpublished observations). A positive satellite cell was 
identified as a dark-stained ovoid body, located between the sarcolemma and basal 
lamina. Figure 5 depicts representative positive cells for Pax7 and MyoD that were used 
during quantification. 
Statistical Analysis 
Data is reported as mean ± SEM. Differences between groups were measured 
using a 2 (exercise) by 4 (treatment) factorial analysis of variance (ANOVA). All post-
hoc tests were completed using Fisher's LSD. 
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Figure 5: Representative rat skeletal muscle fibres immunostained for satellite cells; (A) 
Pax7 and (B) MyoD (400x magnification). 
31 
Results 
Serum Estrogen Levels 
Exercise treatment did not significantly influence serum estrogen levels compared 
to treatment-matched control animals. As a result, serum estrogen levels were pooled into 
four groups: Sham (S), Estrogen supplemented (E), Agonist supplemented (A) and 
Estrogen and Agonist supplemented (EA). As depicted in Table 1, the E and EA 
supplemented animals had significantly higher serum estrogen levels compared to the S 
and A groups (P < 0.01). 
Body Weights 
Since exercise did not influence animal body weight, animals were pooled 
according to treatment group. The S group had significantly greater body weights than all 
other treatment groups (P < 0.01). In addition, the EA group weighed significantly less 
than the E and A groups (P < 0.05). Estrogen and/or PPT supplementation therefore 
significantly reduced body weight compared to S treated rats (Table 2). These effects on 
body weights are typically seen in studies involving estrogen (Enns et al., 2008; Enns & 
Tiidus, 2008; Tiidus et al, 2005). 
Uterine Weights 
The activation of uterine ERs when bound with estrogen or an estrogen agonist 
has been shown to stimulate uterine growth (Harris et al., 2002; Katzenellenbogen et al., 
1995). As such, wet uterine weights were used to verify the effective delivery of PPT and 
estrogen to the uterine ERs. As shown in Table 2, supplementation with estrogen and/or 
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PPT significantly increased uterine weight compared to the S group (P < 0.01). 
Additionally, uterine weight in the E group was significantly greater than the A group (P 
< 0.05); while the EA group had a significantly higher uterine weight compared to all 
treatment groups (P < 0.05). When the uterine weights were normalized to overall body 
weight of the rats, these same trends were observed (Table 2). 
p-Glucuronidase Activity 
Measurement of P-Glucuronidase activity is a marker of muscle damage where 
increased activity indicates increased muscle damage (Salminen & Kihlstrom, 1985). As 
expected, the Ex S group had a significant increase in P-Glucuronidase activity in the 
soleus muscle 72 hours post-exercise compared to the Con S group (Table 3). An 
attenuation of muscle damage was seen in the Ex A group and the Ex EA group 
demonstrated by a significantly lower P-Glucuronidase activity compared to the 
treatment-matched S group (P < 0.01). Similar, non-significant trends for P-
Glucuronidase activity were seen in the white vastus muscle as shown in Table 3. 
Satellite Cells 
Quiescent, activated and proliferating satellite cells were measured using the 
marker Pax7 (Hawke & Garry, 2001). In the white vastus muscle, a main effect for 
exercise was observed where a significant increase in satellite cells was found in the Ex 
groups compared to treatment-matched Con groups (P < 0.01). In addition, the E, A and 
EA groups had a significantly greater number of satellite cells post-exercise compared 
with the treatment-matched S group (P < 0.01), as shown in Figure 6. 
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Figure 7 demonstrates the same effects in the soleus muscle where a significant 
increase in satellite cells was found in the Ex groups compared to the treatment-matched 
Con group (P < 0.01). A significant increase in satellite cells was also found in the E, A 
and EA groups post-exercise compared to the treatment-matched S group (P < 0.05). 
MyoD was used to positively mark activated and proliferating satellite cells 
(Cornelison & Wold, 1997). As depicted in Figure 8, a main effect for exercise was 
observed in the white vastus muscle where a significant increase in satellite cells was 
found in the Ex groups compared to the treatment-matched Con groups (P < 0.01). The E, 
A and EA groups also had a significantly greater number of satellite cells present post-
exercise compared with the treatment-matched S group (P < 0.01). 
Figure 9 demonstrates the same effects in the soleus muscle where a significant 
increase in satellite cells was observed in the Ex groups compared with the treatment-
matched Con groups (P < 0.01). The E, A and EA groups also had a significant increase 
in satellite cells post-exercise compared to the treatment-matched S group (P < 0.01). 
Furthermore, an additional significant increase in satellite cell numbers was found in the 
EA group post-exercise compared to the treatment-matched E and A groups (P < 0.01). 
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Table 1; Serum estradiol levels for sham, estrogen, PPT and E + PPT groups. Values are 
pooled Mean ± SEM as no significant differences were observed between treatment-
matched control and exercise values. * P < 0.01, compared with treatment-matched Sham 
group. % P < 0.01, compared with treatment-matched PPT group. 
Serum Estradiol 
(PB ml"1) 
Sham 
11 ±0.9 
Estrogen 
91±15*$ 
PPT 
34 ± 0.9 
E + PPT 
90 ±10*J 
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Table 2: Animal body weights and uterine weights for sham, estrogen, PPT and E + PPT 
treatment groups. Values are pooled Mean ± SEM as no significant differences were 
observed between treatment-matched control and exercise values. * P < 0.01, compared 
with treatment-matched Sham group, f P < 0.05, compared with treatment-matched 
Estrogen group. % P < 0.01, compared with treatment-matched PPT group. 
Body weight, g 
Uterine Weight, 
g 
Uterine weight, 
g lOOg"1 body 
weight 
Sham 
309 ± 4 
0.110 ±0.009 
0.037 ± 0.004 
Estrogen 
272 ± 3* 
0.409 ±0.161* 
0.152 ±0.010* 
PPT E + PPT 
278 ±2* 261±3*ft 
0.332 ±0.018*t 0.460 ± 0.022*tJ 
0.122 ±0.006*1 0.180 ±0.010*f$ 
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Table 3: Changes in soleus and white vastus muscle P-Glucuronidase activity with 
downhill running. Values are Mean ± SEM. * P < 0.01, compared with treatment-
matched Sham group, f P < 0.05, compared with treatment-matched Estrogen group. 
% P < 0.05, compared with treatment-matched control group. 
Sham Estrogen PPT E + PPT 
Soleus 
Control 
Exercise 
White Vastus 
Control 
Exercise 
4.70 ±0.34 
7.18±0.92J 
3.35 ±0.37 
3.45 ±0.33 
4.56 ±0.21 
6.04 ±1.00 
2.73 ± 0.42 
4.16 ±0.46 
5.21 ±0.18 
5.55 ±0.36* 
3.39 ±0.46 
3.14 ±0.33 
3.99 ± 0.43 
4.42 ± 0.34*t 
2.70 ±0.38 
3.42 ±0.38 
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Figure 6: Effects of supplementation with estrogen, PPT and a combination of estrogen 
and PPT on the number of positive muscle fibres for the satellite cell marker, Pax7, in rat 
white vastus muscle 72 hours following downhill running. Values are Means ± SEM. 
a
 P < 0.01 compared to Control (unexercised). b P < 0.01 compared to Sham treated. 
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Figure 7: Effects of supplementation with estrogen, PPT and a combination of estrogen and 
PPT on the number of positive muscle fibres for the satellite cell marker, Pax7, in rat soleus 
muscle 72 hours following downhill running. Values are Means ± SEM.a P < 0.01 compared 
to Control (unexercised). P < 0.05 compared to Sham treated. 
39 
a,b a,b 
a,b , L. 
IMS ham 
• Estrogen 
DPPT 
OBE + PPT 
Control Exercise 
Figure 8: Effects of supplementation with estrogen, PPT and a combination of estrogen and 
PPT on the number of positive muscle fibres for the satellite cell marker, MyoD, in rat white 
vastus muscle 72 hours following downhill running. Values are Means ± SEM. a P < 0.01 
compared to Control (unexercised). b P < 0.01 compared to Sham treated. 
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Figure 9: Effects of supplementation with estrogen, PPT and a combination of estrogen and 
PPT on the numbers of positive muscle fibres for the satellite cell marker, MyoD, in rat 
soleus muscle 72 hours following downhill running. Values are Means ± SEM. a P < 0.01 
compared to Control (unexercised). b P < 0.01 compared to Sham treated. c P < 0.05 
compared to Estrogen treated and PPT treated. 
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Discussion 
Previous research has shown that estrogen augments satellite cell proliferation in 
skeletal muscle post-exercise (Enns et al., 2008; Enns & Tiidus, 2008; Tiidus et al., 
2005). While estrogens' mechanism of action in the skeletal muscle repair process is not 
fully understood, an ER-mediated pathway has been postulated. An ERa agonist, PPT, 
was used to examine the role of ERa in satellite cell activation. 
The findings of this study show that estrogen-related augmentation of satellite cell 
activation and proliferation following exercise acts through an ER-mediated mechanism 
and that the ERa plays a major role in this regulation. Animals supplemented with 
estrogen, PPT and a combination of estrogen and PPT all demonstrated a significant 
increase in total (Pax7-positive) and activated (MyoD-positive) satellite cells post-
exercise, compared to OVX sham animals. In addition, sole stimulation of ERa by PPT 
resulted in the same degree of satellite cell augmentation compared to animals 
supplemented with estrogen, indicating a key role for ERa in the skeletal muscle repair 
process. 
These results corroborate findings by Enns et al. (2008) where use of an ER 
antagonist, ICI 182,780, eliminated the estrogen-induced increases in total, activated and 
proliferating satellite cells post-exercise. In this study, animals supplemented with a 
combination of estrogen and ICI 182,780 had significantly fewer satellite cells present 
post-exercise compared to estrogen supplemented animals as well as the sham animals. 
These results support estrogens' mechanism of action through estrogen receptors. 
The significant increases in uterine weights observed in the PPT and estrogen plus 
PPT groups can verify that PPT, as used in this study, did bind ERs. Although this study 
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cannot fully elucidate the specific role of ERp in post-exercise augmentation of satellite 
cell numbers, the lack of significant difference between estrogen and PTT alone or in 
combination on post-exercise satellite cell numbers may suggest that the primary effects 
of estrogen are manifested through ERa. Different actions for ERa and ERp have been 
identified in other cellular processes including GLUT-4 expression; ERa acting as a 
positive regulator and ERp acting in an inhibitory fashion (Barros et al., 2006). The 
presence of the ERa has also been shown to play a role in reducing body weight in mice 
whereas ERp had no such effect (Brown et al., 2009). While both ERa and ERP are 
present in skeletal muscle and have a similar binding affinity for estrogen (Hall et al., 
2001), it is possible that each receptor regulates different cellular events. 
Animals supplemented with estrogen alone and in combination with PPT had an 
8-fold increase in serum estrogen levels compared to animals without estrogen. Female, 
ovary-intact rats experience cycling estrogen levels over a three to four day estrous cycle. 
The physiological range of circulating estrogen in rats may be varied depending on the 
estrous cycle stage. Serum estrogen values as low as 10 pg ml"1 in ovary intact rats have 
been reported (Persky et al., 2000), while values as high as 285 pg ml"1 have also been 
found (McNulty et al., 2000). Animals in this study experienced a continued, unvaried 
exposure of estrogen within the normal physiological range (90-91 pg ml"1). 
It is noteworthy that animals supplemented with both estrogen and PPT 
manifested a further significant increase in activated satellite cells in the soleus muscle, 
relative to the smaller augmentation induced by estrogen supplemented and PPT 
supplemented groups alone. This finding was not seen in the white vastus muscle or in 
either muscle for the total number of satellite cells (Pax7-positive). 
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The reason for this increased augmentation of satellite cells is not known. The 
combination of estrogen and PPT supplementation provides a greater amount of available 
substrate to activate ERs. This, coupled with the observation that type I muscle fibres, 
including soleus, have a greater number of ERas compared to type II muscle fibres 
(Lemoine et al., 2002b), could result in the activation of a greater number of ERas and a 
subsequent further augmentation of satellite cells in the soleus muscle. However, as no 
fibre type difference was observed in Pax7-positive satellite cells this remains 
speculative. One can speculate that the combined increase in circulating estrogen and 
PPT levels may stimulate ERs outside of skeletal muscle that influence satellite cell 
activation specifically. However, it is not known if ERs are present on satellite cells 
themselves. 
The downstream signalling pathways involved in satellite cell augmentation 
following ERa activation are not entirely understood. Various pathways that are involved 
in muscle growth and repair may play a role. The Akt-mTOR pathway, for example, 
regulates protein synthesis in muscle (Sitnick et al., 2006). Estrogen has been shown to 
stimulate this pathway in cardiac muscle, however, it is unclear as to whether or not 
estrogen stimulates this pathway through an ER-mediated process (Patten et al., 2004). 
Activation of ERa by estrogen has been shown to stimulate the PI3 kinase-Akt pathway, 
leading to an increase in protein synthesis and muscle growth (Patten et al., 2004; Pedram 
et al., 2002; Sitnick et al., 2006). Estrogen is also involved in the activation of two 
immediate early genes c-fos and egr-1 in proliferating myoblasts through an ER-mediated 
mechanism (Kahlert et al, 1997). Stimulation of these pathways by estrogen appears to 
regulate muscle growth and repair to some extent; further investigation for the role of 
44 
these pathways in satellite cell activation and proliferation is needed to further elucidate 
these and other possibilities. 
Various growth factors may also be involved in the estrogen-stimulated 
augmentation of satellite cell activation and proliferation. Numerous studies have 
reported increases in IGF-I mRNA expression in the uteri of rats following estrogen 
supplementation (Huynh & Pollak, 1993; Kamanga et al., 2008a). Furthermore, this 
estrogen-induced augmentation of IGF-I may be an ER-mediated process as use of the 
ER antagonist, ICI 182 780, eliminated the estrogen-induced increase in IGF-I gene 
expression (Huynh & Pollak, 1993; Kassem et al., 1998; Stygar et al., 2003). Since IGF-I 
is a known regulator of satellite cell proliferation and differentiation (Chakravarthy et al., 
2000; Hawke & Garry, 2001; Johnson et al., 1990; Mills et al., 2007), it is possible that 
estrogen, through receptor-mediated mechanisms, may act to increase IGF-I expression in 
skeletal muscle leading to the augmentation of satellite cell proliferation and 
differentiation. 
HGF is another known regulator of satellite cell activation and proliferation which 
may also be influenced by estrogen (Allen et al., 1995; Tatsumi et al., 1998). Estrogen is 
reported to increase nitric oxide synthase (NOS) and nitric oxide (NO) levels in animal 
(Node et al., 1997) and human models (Caulin-Glaser et al., 1997). Following skeletal 
muscle damage, NO has been shown to regulate the release of HGF (Tatsumi, 2002); 
moreover, inhibition of NOS, and subsequent decrease in NO levels, leads to a reduction 
in activated satellite cells (Anderson et al., 2000). Therefore, the presence of estrogen 
may act to indirectly augment satellite cell activation through NO-mediated stimulation 
of HGF. Further research into the role of estrogen and skeletal muscle ER involvement 
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with NO regulation of satellite cell activation and proliferation also needs to be 
conducted to follow up on these possibilities. 
The results of this study may have potential implications for post-menopausal 
women. Post-menopausal women suffer higher rates of sarcopenia and tend to develop it 
at an earlier age compared to men (Sipila et al., 2001). Given that estrogen seems to 
stimulate satellite cell activity, decreased estrogen levels in post-menopausal women may 
be a contributing factor to the development of sarcopenia and also potentially to 
diminished rates of muscle repair capacity in older females. 
In conclusion, estrogen mediates satellite cell activation and proliferation in 
skeletal muscle through an ER-mediated mechanism, with ERa playing a key role. Future 
research focusing on the downstream signalling pathways involved in estrogen-induced 
satellite cell activation will aid in the understanding of the factors and pathways involved 
in the skeletal muscle repair process. In addition, the differing roles of ERa and ERP in 
skeletal muscle damage, inflammation and repair are worthy of study as their differing 
roles may present pharmacological implications for estrogen and ER-specific agonists 
and antagonists. 
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Chapter Three 
Discussion & Conclusions 
Estrogen has been shown to play a key role in skeletal muscle by influencing 
skeletal muscle damage, inflammation and repair. Estrogen seems to have a protective 
role in skeletal muscle as it attenuates post-exercise calpain activity, decreases membrane 
damage and reduces the degree of damage sustained by the muscle (Enns et al., 2008; 
Enns & Tiidus, 2008; Tiidus et al, 2001). Estrogen also attenuates the inflammatory 
response by decreasing neutrophil and macrophage infiltration into the muscle post-
exercise (Enns et al., 2008; Tiidus et al., 2001). Furthermore, estrogen plays a role in 
skeletal muscle repair, though its mechanisms of action are not yet fully understood. 
The objective of this study was to examine the role of ERa in the estrogen-
induced augmentation of satellite cells in skeletal muscle. While previous studies have 
shown an estrogen-induced augmentation of satellite cells in rat skeletal muscle post-
exercise compared to OVX animals, estrogens' mechanism of action for this process was 
not fully understood (Enns et al., 2008; Enns & Tiidus, 2008; Tiidus et al., 2005). Given 
that both ERa and ERp are present in skeletal muscle (Wiik et al., 2003) and are 
upregulated with exercise (Lemoine et al., 2002; Wiik et al., 2005) it had been postulated 
that estrogen may influence satellite cells through an ER-mediated mechanism. This was 
examined through the use of PPT. 
PPT is an ERa agonist that binds to the ERa with a 50% greater binding affinity 
than estrogen (Kraichely et al., 2000; Stauffer et al., 2000). PPT has been shown to 
effectively mimic estrogen actions in numerous studies as its administration decreases 
food intake, meal size and body weight (Roesch, 2005; Santallo et al., 2007), while 
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increasing uterine weight in OVX rats (Harris et al., 2002; Katzenellenbogen et al., 
1995). In this study, the collected uterine weights confirmed that the administered doses 
of estrogen and PPT were sufficient to stimulate ERs. Use of PPT allowed for the specific 
action of the ERa in the skeletal muscle repair process to be elucidated. 
The main finding of this study was that estrogen acts through an ER-mediated 
mechanism to augment satellite cell activation in skeletal muscle, with ERa playing a 
primary role. PPT stimulated a significant post-exercise increase in total (Pax7-positive) 
and activated (MyoD-positive) satellite cells to the same extent as estrogen. Furthermore, 
supplementation with PPT and a combination of estrogen and PPT may play a protective 
role in skeletal muscle by decreasing the degree of muscle damage; this is depicted by a 
decrease in P-Glucuronidase activity compared to sham treated animals post-exercise in 
the soleus muscle. Similar findings have been reported by Enns et al. (2008) and Enns & 
Tiidus (2008). 
Future research focusing on the downstream signalling pathways that follow ERa 
activation by estrogen is needed. Activation of ERa by estrogen seems to be the initial 
step in a cascade of events that leads to satellite cell augmentation; though the pathways 
and factors involved following ERa activation remain elusive. A pathway that may 
potentially play a role is the PI3 kinase-Akt pathway. Activation of ERa by estrogen 
stimulates p85, a regulatory subunit of the PI3 kinase-Akt pathway, leading to its 
activation (Patten et al., 2004). Since the PI3 kinase-Akt pathway stimulates protein 
synthesis and muscle growth, one can speculate that its ERa-mediated activation by 
estrogen may also elicit a cascade of events that stimulate satellite cell activation and 
proliferation (Patten et al., 2004; Pedram et al., 2002; Sitnick et al., 2006). 
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Estrogen also increases IGF-I expression through an ERa-mediated mechanism. 
IGF-I is a known regulator of satellite cell proliferation and differentiation and plays a 
key role in skeletal muscle repair and hypertrophy (Chakravarthy et al., 2000; Hawke & 
Garry, 2001; Johnson et al., 1990; Mills et al., 2007). Interestingly, IGF-I, like estrogen, 
has also been shown to activate the PI3 kinase-Akt pathway in myoblasts (Latres et al., 
2005; Rommel et al., 2001). Therefore estrogen may augment satellite cell activation and 
proliferation through the direct ERa-mediated stimulation of IGF-I and the PI3 kinase-
pathway; in addition, IGF-I may further contribute to the skeletal muscle repair process 
by activating the PI3 kinase-Akt pathway as well. Overall, activation of the ERa by 
estrogen may, therefore, elicit various event cascades that act to augment satellite cell 
activation and proliferation. 
IGF-I may also indirectly augment satellite cells through its influence on ERs. 
Estrogen does not appear to significantly influence ER transcriptional activity in non-
reproductive organs as peak ER transcriptional activity reportedly occurs in the diestrus 
stage of the estrous cycle (Ciana et al., 2003). IGF-I, on the other hand, has been shown 
to increase ER transcriptional activity in mice in the absence of estrogen (Cenni & 
Picard, 1999). Given that ERa and ERp are expressed in human skeletal muscle in 
individuals with varying levels of estrogen including children, male and female adults 
and post-menopausal women (Wiik et al., 2009), one may speculate that ER expression in 
skeletal muscle may be regulated, in part, by IGF-I. IGF-I, therefore, may not only play a 
role in the skeletal muscle repair process by stimulating satellite cell activation and 
proliferation and the PI3 kinase-Akt pathway, it may also influence ER transcriptional 
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activity. The role IGF-I plays in the skeletal muscle repair process specifically in relation 
to estrogen therefore warrants further investigation. 
There is some controversy over whether or not estrogen does, in fact, enhance 
post-exercise muscle recovery and repair. While animal models consistently show that 
estrogen enhances post-exercise muscle recovery and repair, human studies report 
equivocal evidence. Some human studies, for example, have reported that no gender 
differences exist in the degree of structural damage and muscle force and strength deficits 
incurred by the muscle fibre following eccentric exercise (Sayers & Clarkson, 2001; 
Stupka et al., 2001). In addition, gender differences have not been found in some studies 
looking at muscle strength recovery post-exercise (Sayers & Clarkson, 2001; Thompson 
et al., 1997). Nevertheless, there are human studies that do show decreased levels of 
creatine kinase in women compared to men post-exercise, indicating a decreased degree 
of muscle damage in women (Sewright et al., 2008; Stupka et al., 2000). These studies, 
coupled with animal studies that demonstrate an estrogen-induced decrease in post-
exercise muscle damage, inflammation and an augmentation of muscle repair (Enns et al., 
2008; Enns & Tiidus, 2008; Tiidus et al., 2001; Tiidus et al., 2005), support the role of 
estrogen in mediating skeletal muscle damage and repair. 
The influence of estrogen on skeletal muscle damage, inflammation and repair 
may, therefore, have potential implications for post-menopausal women. Sarcopenia 
typically affects individuals aged 65 and older and involves a loss of muscle mass that 
can severely reduce muscular strength and functional ability (Thompson, 2007). Since an 
increased incidence of sarcopenia in post-menopausal women compared to men of the 
same age has been reported, it has been postulated that the development of sarcopenia 
50 
may be a consequence of decreased circulating estrogen levels in post-menopausal 
women (Sipila et al., 2001). 
Given that estrogen plays a role in the skeletal muscle repair process through the 
augmentation of satellite cell activation and proliferation, impairment in satellite cell 
function may contribute to sarcopenia. In fact, an age-related decline in satellite cell 
activation (Conboy et al., 2003) and proliferation (Mouly et al., 2005) has been reported. 
In addition, Shefer et al. (2006) has reported a significant decline in the total number of 
satellite cells present in human myofibers with age. One may therefore speculate that the 
impairment of muscle repair in post-menopausal women may be due the decreased levels 
of circulating estrogen, causing impairment in satellite cell activation and proliferation. 
In order to counteract sarcopenia, research has shown that women who participate 
in strength training regimes can increase muscle cross-sectional area, force and strength 
(Brown et al., 1997, Sipila et al., 1996). Hormone replacement therapy (HRT) has also 
been reported to increase muscular strength in the back extensor and flexor muscles 
(Heikkinen et al., 1997) and in lower limb muscle groups in post-menopausal women 
(Greeves et al. 1999; Sipila et al., 2001). Moreover, Dionne et al. (2000) found a further 
reduction in sarcopenia in women participating in both strength training and HRT 
compared to those participating in exercise regimes alone. HRT, therefore, seems to play 
a key role in increasing skeletal muscle strength and mass in post-menopausal women. 
Given this positive benefit of HRT in skeletal muscle, along with its other 
associated benefits which include the prevention of osteoporosis, HRT also has negative 
effects. Use of HRT has been link to an increased risk of developing venous 
thromboembolic events, gallbladder disease, and breast cancer (Mosca et al., 2001). As 
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result, its use is not recommended for women who may already have an increased 
susceptibility for these diseases. 
The development of pharmacological estrogen mimicking therapies that target 
specific pathways and ERs could have dramatic implications for post-menopausal 
women. Use of an ERa agonist, for example, could target skeletal muscle (amongst other 
organs) to augment satellite cell activation and proliferation to increase muscle repair in 
post-menopausal women. This may be refined to possibly avoid negative side effects 
from HRT that are caused by non-receptor mediated estrogen pathways or in pathways 
involving activation of the ERp\ Significant further research needs to be conducted in this 
area, however. 
Overall the results of this study, coupled with findings from Enns et al. (2008), 
demonstrate that estrogen augments satellite cell activation and proliferation through an 
ER-mediated mechanism. Furthermore, use of an ERa agonist revealed a key role for the 
ERa in the skeletal muscle repair process. Various downstream signalling pathways and 
factors may be involved in the estrogen-induced augmentation of satellite cell activation 
and proliferation. Further investigation into these ERa-mediated signalling cascades are 
worthy of study as they may have pharmacological and intervention implications for 
post-menopausal women. 
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Appendix A 
P-Glucuronidase Enzyme Assay 
Reaction 
p-nitrophenyl-beta-D-glucuronide +H20 *" alcohol + D-glucuronide + p-nitrophenyl 
Reagent Procedure 
1. Sodium acetate (anhydrous) (C2H302Na) (0.1N) (mw 82.03) 
0.82 gin 100 ml of H20 pH4.2 
2. Glycine Buffer (0.1M) pH 10.8 
A) 0.375g glycine (C2H5N02, mw 75.07) + 0.2922g NaCl (mw 58.44) in 50 ml H20 
B) 0.4 g of NaOH (mw 40) in 100 ml of H20 
Mix 52.2 ml of A and 47.8 ml of B and pH to 10.8 
3. Substrate: p-nitrophenyl-beta-D-glucuronide (5mM) (sigma N-1627) (mw 315.2) 
7.88 mg in 5 ml H20 
Procedure 
1. Homogenize tissue (10-20 mg; optimal 15 mg) in glass pestle using a 33.33:1 
(3%) dilution using distilled water. 
-use 16.66667 times the mass of tissue, do this 2 times 
2. Add 50 ul of homogenate and water to appropriately labeled test tube 
3. Add 450 ul of Acetate buffer to tubes using repeater pipette 
4. Preincubate tubes in 37°C bath for 5 minutes 
5. Add 250 JJ.1 of substrate using repeater pipette 
6. Incubate for 16-18 hours 
7. Add 1.5 ml of cold glycine buffer using repeater pipette 
8. Cool in ice water for 10 minutes 
9. Centrifuge at 3500 rpm for 10 minutes (temp 4°C) 
10. Read on spectrophotometer at 420 nm. 
Standard Preparation 
Standard: p-nitrophenol (mw 139.1) 
Standard, mM To make: 
0.125 Take 563 ul of 10 mM p-NP stock and add 437 ul dH20 
0.0625 Take 500 ul of 0.125 mM solution and add 500 ul dH20 
0.03125 Take 500 ul of 0.0625 mM solution and add 500 ul dH20 
0.015625 Take 500 ul of 0.03125 mM solution and add 500 ul dH20 
0 (distilled water) 
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Appendix B 
Lowry Protein Assay 
PROCEDURE: 
1. Use 12*75 mm culture tubes and do samples, standards, and blanks in triplicate. 
2. Add 50 ul of standards to appropriately labelled tubes. 
3. Add 50 ul of water to tubes labelled REAGENT BLANK. 
4. Prepare a 20:1 dilution of homogenizing media (10 ul media + 190 ul water). Add 50 
|il of dilute media to tubes labelled SAMPLE BLANK. 
5. Prepare a 20:1 dilution of EACH tissue sample (10 JJ.1 sample + 190 ul water). Add 50 
ul of dilute sample to tubes labelled SAMPLE. 
6. Add 0.5 ml of alkaline copper reagent to all tubes. 
7. Mix well and let stand for 10 minutes at 25°C (room temperature). 
8. Add 2.0 ml of phenol reagent to each tube. Mix each tube individually 
IMMEDIATELY after adding phenol reagent. 
9. Incubate for 5 minutes at 55°C. 
10. Cool in tap water for 1 minute. 
11. Read on spectrophotometer at 650 nm. 
54 
REAGENTS: 
1. ALKALINE COPPER REAGENT: 
0.05 g CuS04.5H20 
10.00 gNa2C03 
0.10 g POTASSIUM SODIUM TARTRATE 
2.00gNaOH 
TO 100 ml WATER ADD THE CuS04 AND DISSOLVE COMPLETELY. ADD 
THE REMAINING REAGENTS IN ORDER. STORE AT 20°C FOR 2 WEEKS. 
2. FOLIN-CIOCALTEU PHENOL REAGENT: f Sigma-Aldrich, St. Louis. MO) 
TO 80 ml WATER ADD 5.0 ml of 2 N PHENOL REAGENT. MAKE FRESH 
DAILY. 
3. BOVINE SERUM ALBUMIN STANDARD. 1.0 mg/ml: (BSA.Sigma-Aldrich. St. 
Louis, MO) 
ADD 10 mg of BSA TO 10 ml WATER. MIX BY INVERSION. SERIAL 
DILUTE TO OBTAIN SOLUTIONS AS FOLLOWS: 
1.0 mg/ml 
0.5 mg/ml 
0.25 mg/ml 
0.125 mg/ml 
0.0 mg/ml 
CALCULATION: 
(A650 of sample - A^o of sample blank) 
(A65o of standard - A65o of reagent blank) 
Multiply by 
Concentration of Standard (mg/ml) * 20 (dilution factor) = Protein concentration, mg/ml 
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Appendix C 
Pax7 Immunohistochemistry 
Use frozen sections of rat muscle cut 7-10 microns thick. 
1. Let slides air dry for 5 min or until warmed up to room temperature. 
2. Fix sections with 100% cold acetone for 10 min. 
3. Let slides air dry for 5-10 min. 
4. Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min. 
5. Wash in PBS for 3 x 5 min. 
6. Apply 0.6% H2O2 (in absolute methanol) for 10 min. 
7. Wash in PBS for 3 x 5 min. 
8. Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30 
min. Tap off excess. 
9. Incubate in primary antibody: Pax 7 (1/20 diluted in blocking solution) for 1 h. 
10. Wash in PBS for 3 x 5 min. 
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min. 
12. Wash in PBS for 3 x 5 min. 
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min. 
14. Wash in PBS for 3 x 5 min. 
15. Apply Vector NovaRed stain for 5 min (or until desired intensity is achieved). 
16. Rinse in dH20 liberally from wash bottle, then wash in bath for 2 x 5 min. 
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and rinse 
off with running 37°C tap water for 30 s). 
18. Place a drop of permanent mounting medium on cover slip and place slide upside 
down onto cover slip so that mounting medium covers section completely. 
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles. 
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Appendix D 
MyoD Immunohistochemistry 
Use frozen sections of rat muscle cut 7-10 um thick. 
1. Let slides air dry for 5 min or until warmed up to room temperature. 
2. Fix sections with 100% cold acetone for 10 min. 
3. Let slides air dry for 5-10 min. 
4. Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min. 
5. Wash in PBS for 3 x 5 min. 
6. Apply 0.6% H2O2 (in absolute methanol) for 10 min. 
7. Wash in PBS for 3 x 5 min. 
8. Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30 
min. Tap off excess. 
9. Apply primary antibody: MyoD (DakoCytomation, 1/50 diluted in blocking solution) 
overnight at 4°C (in humidity chamber). 
10. Wash in PBS for 3 x 5 min. 
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min. 
12. Wash in PBS for 3 x 5 min. 
13. Apply Bottle 4: Streptavidin-HRP (from DakoLSAB-2 kit) for 10 min. 
14. Wash in PBS for 3 x 5 min. 
15. Apply DAB stain (Vector Laboratories) for 5 min (or until desired intensity is 
achieved). 
16. Rinse in dH20 liberally from wash bottle. 
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 15 s and rinse off 
with running tap water for 30 s). 
18. Place a drop of permanent mounting medium on cover slip and place slide upside 
down onto cover slip so that mounting medium covers section completely. 
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles. 
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